SCHEMBL11543240

SCHEMBL11543240

COC(=O)c1cc([N+](=O)[O-])c(Sc2ccccc2)c(S(=O)(=O)N=CN(C)C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.43
▸ GAA P10253 2/20 0.43
▸ VCAM1 P19320 1/20 0.43
▸ HTT P42858 2/20 0.40
▸ LMNA P02545 1/20 0.39
▸ POLB P06746 1/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ THRB P10828 1/20 0.36
▸ ABL1 P00519 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ ABCC9 O60706 1/20 0.36
▸ ABCC8 Q09428 1/20 0.36
▸ KCNJ11 Q14654 1/20 0.36
▸ KCNJ8 Q15842 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21437398 1.00 MAPT (0.43) MAPTGAAVCAM1HTTLMNA
SCHEMBL11511421 0.92 ALDH1A1 (0.43) MAPTGAAVCAM1HTTLMNA
SCHEMBL21436671 0.87 VCAM1 (0.40) MAPTGAAVCAM1HTTLMNA
SCHEMBL21436670 0.87 VCAM1 (0.40) MAPTGAAVCAM1HTTLMNA
SCHEMBL22922726 0.84 KDM4E (0.42) MAPTGAALMNAMEN1KMT2A
SCHEMBL11512332 0.84 KDM4E (0.42) MAPTGAALMNAMEN1KMT2A
SCHEMBL573281 0.83 VCAM1 (0.45) MAPTGAAVCAM1LMNAPOLB
SCHEMBL573280 0.83 VCAM1 (0.45) MAPTGAAVCAM1LMNAPOLB
SCHEMBL10222900 0.82 VCAM1 (0.46) MAPTGAAVCAM1LMNAPOLB
SCHEMBL574029 0.82 VCAM1 (0.46) MAPTGAAVCAM1LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112969692-A Bumetanide derivatives for the treatment of hyperhidrosis 兹伦汀公司 2021-06-15 — — CN disclosed
EP-3774763-A1 BUMETANIDE DERIVATIVES FOR THE THERAPY OF HYPERHIDROSIS ZILENTIN AG (CH) 2021-02-17 — — EP disclosed
WO-2019193159-A1 BUMETANIDE DERIVATIVES FOR THE THERAPY OF HYPERHIDROSIS Universität Wien (AT) 2019-10-10 — — WO disclosed
US-4161531-A Diuretic and saluretic 5-sulfamoylbenzoic acid derivatives carrying a heterocyclic substituent HOECHST AKTIENGESELLSCHAFT (DE) 1979-07-17 — — US disclosed
US-4118397-A DIURETICS HOECHST AKTIENGESELLSCHAFT (DE) 1978-10-03 — — US disclosed
US-4111953-A DIURETICS HOECHST AKTIENGESELLSCHAFT (DE) 1978-09-05 — — US disclosed
US-4093735-A DIURETICS HOECHST AKTIENGESELLSCHAFT (DT) 1978-06-06 — — US disclosed
US-4010273-A DIURETICS, SALURETICS HOECHST AKTIENGESELLSCHAFT (DT) 1977-03-01 — — US disclosed
Send feedback